<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The clinical course and serology of 16 cases of <z:e sem="disease" ids="C0023364" disease_type="Disease or Syndrome" abbrv="">leptospirosis</z:e> in an area with an unusually high endemic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> rate were studied to gain further insight into the pathology of the secondary immune phase that is typical of the disease </plain></SENT>
<SENT sid="1" pm="."><plain>IgG anticardiolipin antibody concentrations were measured by immunoassay and found to be increased in eight serologically confirmed cases with severe complicated disease, compared with eight patients with relatively uncomplicated <z:e sem="disease" ids="C0023364" disease_type="Disease or Syndrome" abbrv="">leptospirosis</z:e> who had IgG anticardiolipin concentrations within the control reference range </plain></SENT>
<SENT sid="2" pm="."><plain>This previously unreported association suggests that leptospira may induce vascular endothelial injury in severe cases and expose crypt antigens or induce conformational change of cell surface <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0023364" disease_type="Disease or Syndrome" abbrv="">Leptospirosis</z:e> may provide a model for an infective origin of some cases of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>